Green Cross Holdings Corp. is a Korea-based investment holding company principally engaged in the pharmaceutical business. The Company, through its subsidiary, Green Cross Corporation, is engaged in the manufacture and distribution of pharmaceuticals. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. Through its subsidiaries, it also involves in the life insurance, construction and installment of chemical facilities, healthcare related management and consulting services and others.